Influence of stent implantation on erythrocyte aggregation in human native coronary arteries and saphenous vein grafts

Microcirculation

Volumn 23, Issue 8, 2016, Pages 637-645

  Baars, Theodor ^a   Kahlert, Philipp ^a   Baars, Albert ^b   Preibsch, Heike ^c   Rassaf, Tienush ^a   Heusch, Gerd ^a   Kleinbongard, Petra ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

microvascular perfusion; native coronary artery; red blood cell aggregation; saphenous vein graft; stent implantation

Indexed keywords

TROPONIN I;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; ASPIRATION; CELL ADHESION; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERIAL BLOOD; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; CORONARY ASPIRATE; CORONARY STENT; CORONARY STENTING; ERYTHROCYTE AGGREGATION; HUMAN; HUMAN CELL; INTRAVENOUS UROGRAPHY; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR PERFUSION; MIDDLE AGED; PERFUSION; PERIPHERAL VENOUS BLOOD; PLASMA VISCOSITY; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; SAPHENOUS VEIN GRAFT; STABLE ANGINA PECTORIS; VENOUS BLOOD; ADVERSE DEVICE EFFECT; BLOOD VESSEL PROSTHESIS; COMPLICATION; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; PROSTHESIS IMPLANTATION; SAPHENOUS VEIN; STENT;

AGED; ANGINA, STABLE; BLOOD VESSEL PROSTHESIS; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; ERYTHROCYTE AGGREGATION; HUMANS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; SAPHENOUS VEIN; STENTS;

EID: 84997795625     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12326     Document Type: Article

References (67)

1. Baars T, Kleinbongard P, Boese D et al. Saphenous vein aorto-coronary graft atherosclerosis in patients with chronic kidney disease: more plaque calcification and necrosis, but less vasoconstrictor potential. Basic Res Cardiol. 2012;107:303.
2. Kleinbongard P, Baars T, Moehlenkamp S, Kahlert P, Erbel R, Heusch G. Aspirate from human stented native coronary arteries vs. saphenous vein grafts: more endothelin but less particulate debris. Am J Physiol Heart Circ Physiol. 2013;305:H1222–H1229.
3. Kleinbongard P, Boese D, Baars T et al. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res. 2011;108:344–352.
4. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916–931.
5. Pregowski J, Tyczynski P, Mintz GS et al. Incidence and clinical correlates of ruptured plaques in saphenous vein grafts. An intravascular ultrasound study. J Am Coll Cardiol. 2005;45:1974–1979.
6. Heusch G, Kleinbongard P, Boese D et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation. 2009;120:1822–1836.
7. Kleinbongard P, Konorza T, Boese D et al. Lessons from human coronary aspirate. J Mol Cell Cardiol. 2012;52:890–896.
8. Wells R. Microcirculation and coronary blood flow. Am J Cardiol. 1972;29:847–850.
9. Durussel JJ, Berthault MF, Guiffant G, Dufaux J. Effects of red blood cell hyperaggregation on the rat microcirculation blood flow. Acta Physiol Scand. 1998;163:25–32.
10. Vicaut E, Hou X, Decuypere L, Taccoen A, Duvelleroy M. Red blood cell aggregation and microcirculation in rat cremaster muscle. Int J Microcirc Clin Exp. 1994;14:14–21.
11. Yalcin O, Meiselman HJ, Armstrong JK, Baskurt OK. Effect of enhanced red blood cell aggregation on blood flow resistance in an isolated-perfused guinea pig heart preparation. Biorheology. 2005;42:511–520.
12. Cicco G, Pirrelli A. Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension. Clin Hemorheol Microcirc. 1999;21:169–177.
13. Berliner S, Rogowski O, Aharonov S et al. Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J. 2005;149:260–267.
14. Zeltser D, Rogowski O, Berliner S et al. Sex differences in the expression of haemorheological determinants in individuals with atherothrombotic risk factors and in apparently healthy people. Heart. 2004;90:277–281.
15. Martinez M, Vaya A, Server R, Gilsanz A, Aznar J. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane. Clin Hemorheol Microcirc. 1998;18:253–258.
16. Cicco G, Carbonara MC, Stingi GD, Pirrelli A. Cytosolic calcium and hemorheological patterns during arterial hypertension. Clin Hemorheol Microcirc. 2001;24:25–31.
17. Levenson J, Simon AC, Cambien FA, Beretti C. Cigarette smoking and hypertension. Factors independently associated with blood hyperviscosity and arterial rigidity. Arteriosclerosis. 1987;7:572–577.
18. Haude M, Caspari G, Baumgart D, Brennecke R, Meyer J, Erbel R. Comparison of myocardial perfusion reserve before and after coronary balloon predilation and after stent implantation in patients with postangioplasty restenosis. Circulation. 1996;94:286–297.
19. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med. 1985;312:932–936.
20. Leineweber K, Boese D, Vogelsang M, Haude M, Erbel R, Heusch G. Intense vasoconstriction in response to aspirate from stented saphenous vein aortocoronary bypass grafts. J Am Coll Cardiol. 2006;47:981–986.
21. Mintz GS, Nissen SE, Anderson WD et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol. 2001;37:1478–1492.
22. Boese D, von Birgelen C, Zhou XY et al. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol. 2008;103:587–597.
23. Kleinbongard P, Boese D, Konorza T et al. Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosis. Basic Res Cardiol. 2011;106:681–689.
24. Leborgne L, Cheneau E, Pichard A et al. Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft. Am Heart J. 2003;146:501–506.
25. Levine GN, Bates ER, Blankenship JC et al. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574–e651.
26. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 1957;17:237–246.
27. Baars T, Konorza T, Kahlert P et al. Coronary aspirate TNFalpha reflects saphenous vein bypass graft restenosis risk in diabetic patients. Cardiovasc Diabetol. 2013;12:12.
28. Schmidt RF. Physiologie des Menschen. Physiologie des Menschen. 2013;515.
29. Rotstein R, Fusman R, Berliner S et al. The feasibility of estimating the erythrocyte sedimentation rate within a few minutes by using a simple slide test. Clin Lab Haematol. 2001;23:21–25.
30. Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551–2567.
31. Bishop JJ, Popel AS, Intaglietta M, Johnson PC. Rheological effects of red blood cell aggregation in the venous network: a review of recent studies. Biorheology. 2001;38:263–274.
32. Brust M, Aouane O, Thiebaud M et al. The plasma protein fibrinogen stabilizes clusters of red blood cells in microcapillary flows. Sci Rep. 2014;4:4348.
33. Marton Z, Kesmarky G, Vekasi J et al. Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods. Clin Hemorheol Microcirc. 2001;24:75–83.
34. Merrill EW, Cokelet GC, Britten A, Wells RE Jr. Non-newtonian rheology of human blood - effect of fibrinogen deduced by “subtraction”. Circ Res. 1963;13:48–55.
35. Popel AS, Johnson PC. Microcirculation and Hemorheology. Annu Rev Fluid Mech. 2005;37:43–69.
36. Maeda N, Seike M, Kume S, Takaku T, Shiga T. Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule. Biochim Biophys Acta. 1987;904:81–91.
37. Merrill EW, Gilliland ER, Lee TS, Salzman EW. Blood rheology: effect of fibrinogen deduced by addition. Circ Res. 1966;18:437–446.
38. Baumler H, Halbhuber KJ, Stibenz D, Lerche D. Topo-optical investigations of human erythrocyte glycocalyx conformational changes induced by dextran. Biochim Biophys Acta. 1987;923:22–28.
39. Steffen P, Verdier C, Wagner C. Quantification of depletion-induced adhesion of red blood cells. Phys Rev Lett. 2013;110:018102.
40. Armstrong JK, Wenby RB, Meiselman HJ, Fisher TC. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys J. 2004;87:4259–4270.
41. Chien S, Usami S, Dellenback RJ, Gregersen MI, Nanninga LB, Guest MM. Blood viscosity: influence of erythrocyte aggregation. Science. 1967;157:829–831.
42. Klarik Z, Kiss F, Miko I, Nemeth N. Aorto-porto-caval micro-rheological differences of red blood cells in laboratory rats: further deformability and ektacytometrial osmoscan data. Clin Hemorheol Microcirc. 2013;53:217–229.
43. Nemeth N, Miko I, Furka A et al. Concerning the importance of changes in hemorheological parameters caused by acid-base and blood gas alterations in experimental surgical models. Clin Hemorheol Microcirc. 2012;51:43–50.
44. Son KH, Lim CH, Song EJ, Sun K, Son HS, Lee SH. Inter-species hemorheologic differences in arterial and venous blood. Clin Hemorheol Microcirc. 2010;44:27–33.
45. Kameneva MV, Antaki JF, Borovetz HS et al. Mechanisms of red blood cell trauma in assisted circulation. Rheologic similarities of red blood cell transformations due to natural aging and mechanical stress. ASAIO J. 1995;41:M457–M460.
46. Kameneva MV, Antaki JF. Mechanical trauma to blood. In: Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, eds. Handbook of Hemorheology and Hemodynamics. Amsterdam: IOS Press; 2007:206–227.
47. Toth C, Klarik Z, Kiss F, Toth E, Hargitai Z, Nemeth N. Early postoperative changes in hematological, erythrocyte aggregation and blood coagulation parameters after unilateral implantation of polytetrafluoroethylene vascular graft in the femoral artery of beagle dogs. Acta Cir Bras. 2014;29:320–327.
48. Toth C, Kiss F, Klarik Z et al. Following-up changes in red blood cell deformability and membrane stability in the presence of PTFE graft implanted into the femoral artery in a canine model. Korea-Australia Rheol J. 2014;26:209–215.
49. Hardeman MR, Goedhart P, Koen IY. The effect of low-osmolar ionic and nonionic contrast media on human blood viscosity, erythrocyte morphology, and aggregation behavior. Invest Radiol. 1991;26:810–819.
50. Kesmarky G, Feher G, Koltai K, Horvath B, Toth K. Viscosity, hemostasis and inflammation in atherosclerotic heart diseases. Clin Hemorheol Microcirc. 2006;35:67–73.
51. Kimball JP, Sansone VJ, Diters LA, Wissel PS. Red blood cell aggregation versus blood clot formation in ionic and nonionic contrast media. Invest Radiol. 1988;23(Suppl 2):S334–S339.
52. Goel MS, Diamond SL. Adhesion of normal erythrocytes at depressed venous shear rates to activated neutrophils, activated platelets, and fibrin polymerized from plasma. Blood. 2002;100:3797–3803.
53. Gafarovaa ME, Rykovaa SY, Khokhlova MD et al. Red blood cell (dis)aggregation: effect of inhibition of fibrinogen binding. Ser Biomech. 2012;27:69–73.
54. Ren Q, Ye S, Whiteheart SW. The platelet release reaction: just when you thought platelet secretion was simple. Curr Opin Hematol. 2008;15:537–541.
55. Baskurt OK, Meiselman HJ. Activated polymorphonuclear leukocytes affect red blood cell aggregability. J Leukoc Biol. 1998;63:89–93.
56. Schober LJ, Khandoga AL, Dwivedi S et al. The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP(4) receptor activation and platelet function in whole blood. J Thromb Thrombolysis. 2011;32:158–166.
57. Yaylali YT, Susam I, Demir E et al. Increased red blood cell deformability and decreased aggregation as potential adaptive mechanisms in the slow coronary flow phenomenon. Coron Artery Dis. 2013;24:11–15.
58. Driesen RB, Zalewski J, Vanden Driessche N et al. Histological correlate of a cardiac magnetic resonance imaged microvascular obstruction in a porcine model of ischemia-reperfusion. Cardiovasc Pathol. 2012;21:129–131.
59. Good CW, Blankenship JC, Scott TD, Skelding KA, Berger PB, Wood GC. Feasibility and safety of ad hoc percutaneous coronary intervention in the modern era. J Invasive Cardiol. 2009;21:194–200.
60. Mattichak SJ, Dixon SR, Shannon F, Boura JA, Safian RD. Failed percutaneous coronary intervention: a decade of experience in 21,000 patients. Catheter Cardiovasc Interv. 2008;71:131–137.
61. Schwartz RS, Burke A, Farb A et al. Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death relation to epicardial plaque histopathology. J Am Coll Cardiol. 2009;54:2167–2173.
62. Bekkers SC, Yazdani SK, Virmani R, Waltenberger J. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol. 2010;55:1649–1660.
63. Jaffe R, Charron T, Puley G, Dick A, Strauss BH. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation. 2008;117:3152–3156.
64. Rochitte CE. Microvascular obstruction the final frontier for a complete myocardial reperfusion. J Am Coll Cardiol. 2008;51:2239–2240.
65. Heusch G. The coronary circulation as a target of cardioprotection. Circ Res. 2016;118:1643–1658.
66. Baskurt OK, Hardeman MR, Uyuklu M et al. Comparison of three commercially available ektacytometers with different shearing geometries. Biorheology. 2009;46:251–264.
67. Baskurt OK, Uyuklu M, Ulker P et al. Comparison of three instruments for measuring red blood cell aggregation. Clin Hemorheol Microcirc. 2009;43:283–298.